Kaya Holdings, Inc. announced that it expects to receive $4 million in funding
September 01, 2020
Share
Kaya Holdings, Inc. (OTCPK:KAYS) announced a private placement of up to 160 units at a price of $25,000 per unit for proceeds of up to $4,000,000 on September 2, 2020. The Units will be offered and sold on a best efforts basis until December 31, 2020, which may be extended by the company in its sole discretion for a period or periods of up to one hundred eighty 180 days. Each unit consist of 1,000,000 shares of the Company’s common stock, 1,000,000 one-year Class A warrants, each entitling the holder to purchase one additional share, at an exercise price of $0.075 per share, 1,000,000 two year Class B warrants, each entitling the holder to purchase one additional share, at an exercise price of $0.125 per share, 100,000 shares of common stock of Kaya Brands International, Inc. The transaction will include participation from accredited investors. The securities will be offered and sold pursuant to Rule 506(c) promulgated, Regulation D under the Securities Act of 1933, as amended. The minimum investment accepted from any outside investor is $12,500.
Kaya Holdings, Inc. is a holding company. The Company is focused on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and cannabidiol (CBD) products. The Company produces, distributes, and/or sells a full range of cannabis products including flowers, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands. It operates through four subsidiaries, which include Marijuana Holdings Americas, Inc. (MJAI), Kaya Brand International, Inc. (KBI)., and Fifth Dimension Therapeutics, Inc. (FDT). MJAI maintains ownership of the Companyâs Oregon-based cannabis operations. FDT provides psychedelic mind care treatments to veterans suffering from PTSD, addicts seeking to break addiction, individuals with eating disorders, and others with an array of treatment resistant mental health disorders.